Your browser doesn't support javascript.
loading
Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion.
Hirota, Masanori; Isomura, Tadashi; Katsumata, Chieko; Ito, Fusahiko; Watanabe, Masazumi.
Afiliación
  • Hirota M; Department of Cardiovascular Surgery, Tokyo Metropolitan Hiroo Hospital, 10-34-2 Ebisu, Shibuya-ward, Tokyo, 150-0013, Japan. hirotamasanori@yahoo.co.jp.
  • Isomura T; Department of Cardiovascular Surgery, Tokyo Metropolitan Hiroo Hospital, 10-34-2 Ebisu, Shibuya-ward, Tokyo, 150-0013, Japan.
  • Katsumata C; Department of Cardiovascular Surgery, Tokyo Metropolitan Hiroo Hospital, 10-34-2 Ebisu, Shibuya-ward, Tokyo, 150-0013, Japan.
  • Ito F; Department of Cardiovascular Surgery, Tokyo Metropolitan Hiroo Hospital, 10-34-2 Ebisu, Shibuya-ward, Tokyo, 150-0013, Japan.
  • Watanabe M; Department of Cardiovascular Surgery, Tokyo Metropolitan Hiroo Hospital, 10-34-2 Ebisu, Shibuya-ward, Tokyo, 150-0013, Japan.
J Cardiothorac Surg ; 11(1): 81, 2016 May 10.
Article en En | MEDLINE | ID: mdl-27160266
BACKGROUND: Mitral valve repair is preferred over prosthetic replacement. We surgically repaired mitral valve with degenerated sclerotic lesion and demonstrated mid-term results. METHODS: Mitral valve plasty (MVP) was performed with several procedures including ring annuloplasty, leaflet slicing and decalcification. RESULTS: There were 19 males and 19 females with a mean age of 67 ± 12 y.o (n = 38). All patients were successfully treated MVP except one case with unrepairable injuries of the thin leaflet. In patients underwent MVP (n = 37), MVP included ring annuloplasty with a rigid full ring of 32 ± 2 mm (n = 37), leaflet slicing (n = 37), decalcification (n = 15) and artificial chordae (n = 14). Mitral valve area was statistically enlarged by MVP (1.65 ± 0.57 vs 2.51 ± 0.58 cm(2), p < 0.001). Left atrial diameter was statistically reduced after the operation (55 ± 10 vs 46 ± 9 mm, p < 0.001). Severity of MR and right ventricular systolic pressure (RVSP) were statistically decreased after the operation (MR; 1.8 ± 1.0 vs 0.7 ± 0.9, p < 0.001, RVSP; 38 ± 15 vs 30 ± 9 mm Hg, p < 0.001). There were 4 cases with residual MR (Grade II, n = 3; Grade III, n = 1). The 30-days mortality was 0 %. There was one late death due to non-cardiogenic cause (the 3-year survival rate of 97 %) and no redo case due to deterioration of the mitral valve during follow-up period of 21 ± 13 months. CONCLUSIONS: Successful mid-term survival and freedom from reoperation might expect to the durability of MVP in patients with mitral sclerotic lesion.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aterosclerosis / Anuloplastia de la Válvula Mitral / Insuficiencia de la Válvula Mitral Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cardiothorac Surg Año: 2016 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aterosclerosis / Anuloplastia de la Válvula Mitral / Insuficiencia de la Válvula Mitral Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cardiothorac Surg Año: 2016 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido